Astria Therapeutics(ATXS)
搜索文档
Astria Therapeutics(ATXS) - 2019 Q1 - Earnings Call Transcript
2019-05-14 23:45
Catabasis Pharmaceuticals, Inc. (CATB) Q1 2019 Earnings Conference Call May 14, 2019 8:30 AM ET Company Participants Andrea Matthews - Vice President-Corporate Affairs Jill Milne - Chief Executive Officer Joanne Donovan - Chief Medical Officer Andrew Nichols - Chief Scientific Officer Noah Clauser - Vice President of Finance Conference Call Participants Liana Moussatos - Wedbush Securities, Inc. Joel Beatty - Citigroup Hartaj Singh - Oppenheimer & Co., Inc. Operator Good day, ladies and gentlemen, and welco ...
Astria Therapeutics(ATXS) - 2019 Q1 - Quarterly Report
2019-05-14 19:31
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37467 Catabasis Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 26-368716 ...
Astria Therapeutics(ATXS) - 2018 Q4 - Earnings Call Transcript
2019-03-15 02:42
Catabasis Pharmaceuticals, Inc. (CATB) Q4 2018 Earnings Conference Call March 14, 2019 8:30 AM ET Company Participants Andrea Matthews – Vice President-Corporate Affairs Jill Milne – Chief Executive Officer Joanne Donovan – Chief Medical Officer Andrew Nichols – Chief Scientific Officer Noah Clauser – Vice President of Finance Conference Call Participants Hartaj Singh – Oppenheimer Joel Beatty – Citi Operator Good day, ladies and gentlemen, and welcome to the Q4 2018 Catabasis Pharmaceuticals Earnings Confe ...
Astria Therapeutics(ATXS) - 2018 Q4 - Annual Report
2019-03-14 19:31
Use these links to rapidly review the document TABLE OF CONTENTS EXHIBIT INDEX One Kendall Square Bldg. 1400E, Suite B14202 Cambridge, Massachusetts 02139 (Address of principal executive offices) (Zip Code) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SEC ...